Safety Nausea, vomiting, headache, fatigue, diarrhea, and constipation are the highest reported side effects
These include insulin resistance, impaired appetite signaling, and chronic low-grade inflammation, all of which can make weight loss more difficult
BPC-157 may not be appropriate when: Imaging or specialist review has not yet been completed for a suspected structural injury There are acute red flag features (severe weakness, fever, rapid unexplained swelling, neurological changes, unexplained weight loss) The patient has active cancer or a history of certain cancers where angiogenic peptides require careful risk assessment The goal is rapid results without addressing underlying load, rehabilitation, or lifestyle drivers A peptide should not be used to delay evaluation that is clearly warranted
Knowing which type of buyer you are matters
Someone with normal B12 who feels drained despite good habits may find NAD conversations more relevant
Good manners Great execution Mood and energy lifted
